← Back to Search

Behavioral Intervention

Machine Learning for Smoking Cessation

N/A
Recruiting
Led By Emily Hebert, DrPH
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
willingness to quit smoking 14 days after the baseline visit
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-weeks after quit day
Awards & highlights

Study Summary

This trial will test how well a machine learning-based intervention can help people quit smoking.

Who is the study for?
This trial is for individuals who want to quit smoking and are currently smoking more than 5 cigarettes a day. They should have no issues with using nicotine patches, be able to read at a basic level (REALM-SF score ≥4), and own an Android phone (version 5.2+) on which they can install the InsightTM mHealth app.Check my eligibility
What is being tested?
The study tests a personalized intervention that uses machine learning to predict when someone might lapse in their attempt to quit smoking. It includes interviewing-based counseling, nicotine patches, and monitoring through an Android Wear smartwatch.See study design
What are the potential side effects?
Potential side effects may include skin irritation from the nicotine patch and typical withdrawal symptoms from quitting smoking such as irritability, cravings, or difficulty concentrating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You agree to stop smoking within 14 days after the first visit.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-weeks after quit day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-weeks after quit day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of patients who quit smoking as confirmed by absence of salivary cotinine

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Adaptive Treatment plus usual careExperimental Treatment4 Interventions
Group II: Usual careActive Control3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Nicotine
FDA approved

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,467 Previous Clinical Trials
2,619,063 Total Patients Enrolled
The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,917 Total Patients Enrolled
Emily Hebert, DrPHPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Media Library

Adaptive Treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04839198 — N/A
Smoking Cessation Research Study Groups: Adaptive Treatment plus usual care, Usual care
Smoking Cessation Clinical Trial 2023: Adaptive Treatment Highlights & Side Effects. Trial Name: NCT04839198 — N/A
Adaptive Treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04839198 — N/A
Smoking Cessation Patient Testimony for trial: Trial Name: NCT04839198 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still enrolling participants in this experiment?

"The latest data from clinicaltrials.gov reveals that this medical study, which was originally added to the database on November 1st 2021, is not presently looking for participants. Nevertheless, there are 214 alternative studies actively recruiting patients at present."

Answered by AI

How many individuals have been accepted into this research endeavor?

"At present, this research effort is not recruiting patients. It was initially posted on November 1st 2021 and edited most recently on September 27th 2021. For those interested in alternative studies, there are 143 trials needing participants to aid smoking cessation efforts and 71 adaptive treatment programs currently open for enrollment."

Answered by AI

Are there any previously conducted research projects associated with Adaptive Treatment?

"Currently, 71 Adaptive Treatment investigations are in progress and 5 have reached Phase 3. In particular, Greenville, South carolina is a hub for this type of research with 204 testing sites located there."

Answered by AI

Who else is applying?

What state do they live in?
Texas
How old are they?
18 - 65
What site did they apply to?
The University of Texas Health Science Center at Houston
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
2
1

Why did patients apply to this trial?

My grandkids and my health. I can go a few days without smoking then I give in not cause I’m craving so much but more of boredom.
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Phone Call
Recent research and studies
clinicaltrials.govStudy
Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking Cessation
Emily Hebert 2024. "Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking Cessation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04839198.
All > Smoking Cessation
~34 spots leftby Aug 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top